new drug for HIV, Ziagen (abacavir)

Glaxo will soon promote a new drug for HIV, Ziagen (abacavir).

It's a potent nucleoside the same class as Retrovir (zidovudine) or 3TC (lamivudine).

It'll be used in combo therapy with other antiretrovirals.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote